CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
REVENUES	$ 163,749	$ 117,226	$ 415,502	$ 260,328
COST OF REVENUES	47,233	40,936	140,531	88,580
GROSS PROFIT	116,516	76,290	274,971	171,748
OPERATING EXPENSES
Research and development	795,118	895,651	1,544,417	1,981,625
General and administrative	1,510,390	1,498,236	2,892,575	3,096,760
Depreciation	6,244	185,202	12,481	379,934
Amortization	76,689	76,690	153,378	153,379
TOTAL OPERATING EXPENSES	2,388,441	2,655,779	4,602,851	5,611,698
OPERATING LOSS	(2,271,925)	(2,579,489)	(4,327,880)	(5,439,950)
OTHER INCOME (EXPENSE)
Transitional services provided to Pulse Veterinary Technologies, LLC	112,500	90,125	225,000	180,125
Gain on sale of assets		2,065		2,065
Extinguishment of debt (Note 11)	(1,318,781)		(1,318,781)
Interest expense, net	(79,794)	(240,243)	(316,074)	(457,524)
Gain (loss) on foreign currency exchange	(14,207)	392	(17,798)	(6,621)
TOTAL OTHER INCOME (EXPENSE)	(1,300,282)	(147,661)	(1,427,653)	(281,955)
LOSS BEFORE INCOME TAXES	(3,572,207)	(2,727,150)	(5,755,533)	(5,721,905)
OTHER COMPREHENSIVE INCOME (LOSS)
Foreign currency translation adjustments	2,290	(3,593)	13,288	(4,161)
TOTAL COMPREHENSIVE LOSS	(3,569,917)	(2,730,743)	(5,742,245)	(5,726,066)
LOSS PER SHARE:
Net loss - basic (in Dollars per share)	$ (0.17)	$ (0.22)	$ (0.31)	$ (0.46)
Net loss - diluted (in Dollars per share)	$ (0.17)	$ (0.22)	$ (0.31)	$ (0.46)
Weighted average shares outstanding - basic (in Shares)	20,537,517	12,509,657	18,340,586	12,509,657
Weighted average shares outstanding - diluted (in Shares)	20,537,517	12,509,657	18,340,586	12,509,657
NET LOSS	$ (3,572,207)	$ (2,727,150)	$ (5,755,533)	$ (5,721,905)